FDA Approves Generic Aricept to Treat Dementia Related to Alzheimer’s Disease : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

FDA Approves Generic Aricept to Treat Dementia Related to Alzheimer’s Disease

December 18, 2009

Washington,DC (RPRN) 12/18/09 — Please note this is a corrected version of a press release that was posted to FDA's website today. The corrections include a modified headline and a revised second paragraph.

The U.S. Food and Drug Administration approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablet s on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer’s disease.

Orally disintegrating tablets dissolve on the tongue, without having to be swallowed whole. This may make it easier to take the medication for older or disabled patients who have difficulty swallowing.  

“Generics offer greater access to health care for all Americans,” said Gary Buehler, director of the FDA’s Office of Generic Drugs. “Health care professionals and consumers can be assured that FDA-approved generic drugs have met the same rigorous standards as the brand-name drug   and are the same as the branded in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.” 

Alzheimer’s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with Alzheimer’s disease, symptoms first appear after age 60. Alzheimer’s disease is the most common cause of dementia among older people, but it is not a normal part of aging.

Dementia refers to a decline in cognitive function that interferes with daily life and activities. Alzheimer’s disease starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain.

The generic donepezil hydrochloride orally disintegrating tablets, manufactured by Mutual Pharmaceutical of Philadelphia, have been approved in 5 milligram and 10 mg strengths.

For more information:
Consumer Education: Generic Drugs
http://www.fda.gov/Drugs/ResourcesForYou/ucm167906.htm

About the author:

FDA is an agency within the Department of Health and Human Services and consists of seven centers and offices

Click here to see all news from this author/company

Filed Under: BREAKING NEWS, FDA- Pharmaceutical news, Health and Fitness, Lifestyle, PRESS RELEASE

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Le Petit Kids, first childrens outlet sale 30-70%

Los Angeles, CA 08/01/15 · Americas very first kids designer outlet is announcing...

Neurobiologix Launches Methylation Complete Sublingual Enhanced Formula

Austin, TX 07/28/15 · Sublingual Formula Now Includes Additional Bioactive B12 For...

DEA ANNOUNCES 10th NATIONAL PRESCRIPTION DRUG TAKE-BACK

Washington, DC 07/28/15 · DEA Acting Administrator Chuck Rosenberg today announced that...

Publish your press release to 100 digital business news site for $59

New York, NY 07/20/15 · Your press release to be featured on at...

Recombinetics and Newborn Foundation Launch 
Newborn Health Research Institute

SAINT PAUL, MN 07/17/15 · Recombinetics and Newborn Foundation Launch 
Newborn Health Research...

InCycle Becomes Azure Gold Partner

SEATTLE, WA 07/13/15 · InCycle Software, today announced it has achieved a...

Ultraseal's new R-FL-Duplex+ machine sparks interest in casting impregnation

Dusseldorf, Germany 07/08/15 · Ultraseal International attracted great interest in its R-FL-Duplex+...

Dropout announces new website for 2015

London, UK 07/08/15 · The Dropout team are proud to announce the...

Coalition Joins National Coalition for Infant Health

Washington, D.C. 06/25/15 · Newborn Foundation News: Newborn Health leaders convene in DC...

RushPRnews now offers digital news sites +Targeted News outlet Broadcast

SAN FRANCISCO/MONTREAL 06/22/15 · Your press release to be featured on at...